In this report, our team offers a comprehensive analysis of Gastrointestinal Stromal Tumor (GIST) Drug market, SWOT analysis of the most prominent players in this landscape. Along with an industrial chain, market statistics in terms of revenue, sales, price, capacity, regional market analysis, segment-wise data, and market forecast information are offered in the full study, etc.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Clinic
Hospital
Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Gastrointestinal Stromal Tumor (GIST) Drug Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Amcasertib
1.3.2 Anagrelide hydrochloride CR
1.3.3 APG-1351
1.3.4 Binimetinib
1.3.5 Others
1.4 Application Overview
1.4.1 Clinic
1.4.2 Hospital
1.4.3 Others
1.5 Industrial Chain
1.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Amcasertib
2.1.2 Anagrelide hydrochloride CR
2.1.3 APG-1351
2.1.4 Binimetinib
2.1.5 Others
2.2 The Overall Market Performance(Value)
2.2.1 Amcasertib
2.2.2 Anagrelide hydrochloride CR
2.2.3 APG-1351
2.2.4 Binimetinib
2.2.5 Others
3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Clinic
3.3 Hospital
3.4 Others
4 Competitive Analysis
4.1 Ariad Pharmaceuticals, Inc.
4.1.1 Ariad Pharmaceuticals, Inc. Profiles
4.1.2 Ariad Pharmaceuticals, Inc. Product Information
4.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.1.4 SWOT Analysis
4.2 Arog Pharmaceuticals, Inc.
4.2.1 Arog Pharmaceuticals, Inc. Profiles
4.2.2 Arog Pharmaceuticals, Inc. Product Information
4.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.2.4 SWOT Analysis
4.3 Array BioPharma Inc.
4.3.1 Array BioPharma Inc. Profiles
4.3.2 Array BioPharma Inc. Product Information
4.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.3.4 SWOT Analysis
4.4 Astex Pharmaceuticals, Inc.
4.4.1 Astex Pharmaceuticals, Inc. Profiles
4.4.2 Astex Pharmaceuticals, Inc. Product Information
4.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.4.4 SWOT Analysis
4.5 Blueprint Medicines Corporation
4.5.1 Blueprint Medicines Corporation Profiles
4.5.2 Blueprint Medicines Corporation Product Information
4.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.5.4 SWOT Analysis
4.6 Boston Biomedical, Inc.
4.6.1 Boston Biomedical, Inc. Profiles
4.6.2 Boston Biomedical, Inc. Product Information
4.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.6.4 SWOT Analysis
4.7 Calithera Biosciences, Inc.
4.7.1 Calithera Biosciences, Inc. Profiles
4.7.2 Calithera Biosciences, Inc. Product Information
4.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.7.4 SWOT Analysis
4.8 Chipscreen Biosciences Ltd
4.8.1 Chipscreen Biosciences Ltd Profiles
4.8.2 Chipscreen Biosciences Ltd Product Information
4.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.8.4 SWOT Analysis
4.9 Deciphera Pharmaceuticals, LLC
4.9.1 Deciphera Pharmaceuticals, LLC Profiles
4.9.2 Deciphera Pharmaceuticals, LLC Product Information
4.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.9.4 SWOT Analysis
4.10 F. Hoffmann-La Roche Ltd.
4.10.1 F. Hoffmann-La Roche Ltd. Profiles
4.10.2 F. Hoffmann-La Roche Ltd. Product Information
4.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
4.10.4 SWOT Analysis
4.11 Horizon Pharma Plc
4.12 Immunicum AB
4.13 Jiangsu Hengrui Medicine Co., Ltd.
4.14 Kolltan Pharmaceuticals, Inc.
4.15 Natco Pharma Limited
4.16 Nerviano Medical Sciences S.r.l.
4.17 Novartis AG
4.18 Omeros Corporation
5 Competitive Lanscape
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Assessment by Regions
7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) by Regions (2014-2020)
7.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.2 China Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.7 India Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
8.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers
11 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Regions
11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Forecast by Regions (2021-2026)
11.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Regions (2021-2026)
11.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Regions (2021-2026)
11.2 China Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.7 India Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
11.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2021-2026)
12 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Amcasertib
12.3 Anagrelide hydrochloride CR
12.4 APG-1351
12.5 Binimetinib
12.6 Others
13 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Clinic
13.3 Hospital
13.4 Others
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price Forecast (2021-2026)
14.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Profit Forecast (2021-2026)
15 Conclusion